SAN

82.86

+0.08%↑

UCB

267.9

+3.32%↑

SHL.DE

36.38

+0.61%↑

ARGX

643

+3.71%↑

VIE

33.23

+1.75%↑

SAN

82.86

+0.08%↑

UCB

267.9

+3.32%↑

SHL.DE

36.38

+0.61%↑

ARGX

643

+3.71%↑

VIE

33.23

+1.75%↑

SAN

82.86

+0.08%↑

UCB

267.9

+3.32%↑

SHL.DE

36.38

+0.61%↑

ARGX

643

+3.71%↑

VIE

33.23

+1.75%↑

SAN

82.86

+0.08%↑

UCB

267.9

+3.32%↑

SHL.DE

36.38

+0.61%↑

ARGX

643

+3.71%↑

VIE

33.23

+1.75%↑

SAN

82.86

+0.08%↑

UCB

267.9

+3.32%↑

SHL.DE

36.38

+0.61%↑

ARGX

643

+3.71%↑

VIE

33.23

+1.75%↑

Inicio・Lista de Acciones・ICADE.

ICADE.

Cerrado

SectorSanidad

19.82 2.43

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

19.34

Máximo

19.9

Métricas clave
By Trading Economics
Ingresos	60M -31M
Ventas	84M 707M
BPA	-0.41
Margen de beneficios	-4.427
Empleados	983
EBITDA	-152M -14M

Recomendaciones
By TipRanks
Recomendaciones	Venta Fuerte
Estimación a 12 Meses	+3.99% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-115M 1.5B
Apertura anterior	17.39
Cierre anterior	19.82

Noticias sobre sentimiento de mercado

By Acuity

50%

148 / 349 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

21.04 / 21.4 Soporte y Resistencia

ICADE. Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado

Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado

Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

ICADE. previsión

Precio Objetivo

By TipRanks

3.99% repunte

Estimación a 12 Meses

Media 19.82 EUR 3.99%

Máximo 25 EUR

Mínimo 17.1 EUR

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para ICADE. Dist en los últimos 3 meses.

Consenso

By TipRanks

Venta Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para ICADE. Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

21.04 / 21.4Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Sentimiento

By Acuity

148 / 349 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de ICADE.

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth "6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of "1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.